TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
JBM (Healthcare) Ltd. ( (HK:2161) ) has issued an announcement.
JBM (Healthcare) Ltd. has entered into a 2025 License Agreement with Europharm, a subsidiary of Jacobson Pharma Corporation Limited, to use a portion of a factory for three years starting from January 2025. This agreement, involving a monthly license fee of HK$218,000, is classified as a connected transaction under Hong Kong’s Listing Rules, requiring reporting and announcement but exempt from circular and independent shareholders’ approval due to its financial scale.
More about JBM (Healthcare) Ltd.
YTD Price Performance: -0.53%
Average Trading Volume: 2,072,054
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$1.55B
For a thorough assessment of 2161 stock, go to TipRanks’ Stock Analysis page.